Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppa Graceffa

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Cancers|May 16, 2023
Immunomorphological Patterns of Chaperone System Components in Rare Thyroid Tumors with Promise as Biomarkers for Differential Diagnosis and Providing Clues on Molecular Mechanisms of CarcinogenesisLetizia Paladino, Radha Santonocito, Giuseppa Graceffa, et al.
Therapeutic Advances in Medical Oncology|October 14, 2021
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analysesValerio Gristina, Antonio Galvano, Luisa Castellana, et al.
Journal of Clinical Medicine|August 14, 2025
Primary Hyperparathyroidism: 18F-Fluorocholine PET/CT vs. 4D-CT for Parathyroid Identification: Toward a Comprehensive Diagnostic Framework-An Updated Review and RecommendationsGregorio Scerrino, Nunzia Cinzia Paladino, Giuseppa Graceffa, et al.
Journal of Clinical Medicine|August 7, 2021
Predictors of Central Compartment Involvement in Patients with Positive Lateral Cervical Lymph Nodes According to Clinical and/or Ultrasound EvaluationGiuseppa Graceffa, Giuseppina Orlando, Gianfranco Cocorullo, et al.
Cancers|March 1, 2020
Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-AnalysisAntonio Galvano, Marta Castiglia, Sergio Rizzo, et al.
Biology|September 28, 2024
MiRNAs in Extracellular Vesicles as Biomarkers in Plasma of Papillary Thyroid Cancer Patients: A Proof-of-Concept StudyGiuseppa D'Amico, Radha Santonocito, Godfrey Grech, et al.
Critical Reviews in Oncology/Hematology|January 3, 2023
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visibleValerio Gristina, Maria La Mantia, Marta Peri, et al.
International Journal of Molecular Sciences|September 14, 2019
Immunomorphological Pattern of Molecular Chaperones in Normal and Pathological Thyroid Tissues and Circulating Exosomes: Potential Use in ClinicsCeleste Caruso Bavisotto, Calogero Cipolla, Giuseppa Graceffa, et al.
Therapeutic Advances in Medical Oncology|October 7, 2021
Not all <i>KIT</i> 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)Lorena Incorvaia, Giuseppe Badalamenti, Daniele Fanale, et al.
Updates in Surgery|April 16, 2021
The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled studyFabio Medas, Gian Luca Ansaldo, Nicola Avenia, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Cancers|May 16, 2023
Immunomorphological Patterns of Chaperone System Components in Rare Thyroid Tumors with Promise as Biomarkers for Differential Diagnosis and Providing Clues on Molecular Mechanisms of CarcinogenesisLetizia Paladino, Radha Santonocito, Giuseppa Graceffa, et al.
Therapeutic Advances in Medical Oncology|October 14, 2021
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analysesValerio Gristina, Antonio Galvano, Luisa Castellana, et al.
Journal of Clinical Medicine|August 14, 2025
Primary Hyperparathyroidism: 18F-Fluorocholine PET/CT vs. 4D-CT for Parathyroid Identification: Toward a Comprehensive Diagnostic Framework-An Updated Review and RecommendationsGregorio Scerrino, Nunzia Cinzia Paladino, Giuseppa Graceffa, et al.
Journal of Clinical Medicine|August 7, 2021
Predictors of Central Compartment Involvement in Patients with Positive Lateral Cervical Lymph Nodes According to Clinical and/or Ultrasound EvaluationGiuseppa Graceffa, Giuseppina Orlando, Gianfranco Cocorullo, et al.
Cancers|March 1, 2020
Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-AnalysisAntonio Galvano, Marta Castiglia, Sergio Rizzo, et al.
Biology|September 28, 2024
MiRNAs in Extracellular Vesicles as Biomarkers in Plasma of Papillary Thyroid Cancer Patients: A Proof-of-Concept StudyGiuseppa D'Amico, Radha Santonocito, Godfrey Grech, et al.
Critical Reviews in Oncology/Hematology|January 3, 2023
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visibleValerio Gristina, Maria La Mantia, Marta Peri, et al.
International Journal of Molecular Sciences|September 14, 2019
Immunomorphological Pattern of Molecular Chaperones in Normal and Pathological Thyroid Tissues and Circulating Exosomes: Potential Use in ClinicsCeleste Caruso Bavisotto, Calogero Cipolla, Giuseppa Graceffa, et al.
Therapeutic Advances in Medical Oncology|October 7, 2021
Not all <i>KIT</i> 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)Lorena Incorvaia, Giuseppe Badalamenti, Daniele Fanale, et al.
Updates in Surgery|April 16, 2021
The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled studyFabio Medas, Gian Luca Ansaldo, Nicola Avenia, et al.
Pageof 7